ARBUTUS BIOPHARMA CORP (ABUS) Stock Earnings & Estimates
NASDAQ:ABUS - CA03879J1003 - Common Stock
3.71 USD
+0.04 (+1.09%)
3.71 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 39.02M 255.05% | 18.141M -53.51% | 6.171M -65.98% | 14.688M 138.02% | 3.726M -74.63% | 9.009M 141.79% | 57.051M 533.27% | 176.95M 210.16% | |
| EBITDA YoY % growth | -64.03M 10.78% | -76.699M -19.79% | -71.219M 7.14% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -65.46M 10.96% | -78.103M -19.31% | -72.599M 7.05% | -40.762M 43.85% | -49.119M -20.50% | -17.585M 64.20% | -37.195M -111.52% | 68.191M 283.33% | |
| Operating Margin | -167.76% | -430.53% | -1,176.45% | -277.52% | -1,318.28% | -195.19% | -65.20% | 38.54% | |
| EPS YoY % growth | -0.47 43.26% | -0.44 6.57% | -0.37 15.91% | -0.18 51.34% | -0.19 -4.44% | -0.05 72.87% | -0.14 -179.40% | 0.35 343.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 64.87% | -0.03 57.38% | -0.05 64.69% | -0.05 -559.00% | -0.05 -45.16% | -0.05 -70.94% |
| Revenue Q2Q % growth | 1.292M -3.51% | 1.258M -20.08% | 1.102M -37.53% | 1.051M -90.21% | 1M -22.63% | 948.6K -24.59% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.172M 54.13% | -7.952M 42.54% | -11.275M 15.39% | -11.903M -820.11% | -12.593M -54.10% | -13.349M -67.87% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.01 109.09% | -0.05 | 0.06 | 120.64% |
| Q1 2025 Q2Q % growth | -0.13 -30.00% | -0.11 | -0.02 | -23.26% |
| Q4 2024 Q2Q % growth | -0.07 41.67% | -0.08 | 0.01 | 14.22% |
| Q3 2024 Q2Q % growth | -0.09 25.00% | -0.10 | 0.01 | 6.73% |
| Q2 2024 Q2Q % growth | -0.11 -10.00% | -0.10 | -0.01 | -11.41% |
| Q1 2024 Q2Q % growth | -0.10 | -0.11 | 0.01 | 10.87% |
| Q4 2023 Q2Q % growth | -0.12 14.86% | -0.12 | 0.00 | 0.30% |
| Q3 2023 Q2Q % growth | -0.12 | -0.12 | 0.00 | -3.38% |
| Q2 2023 Q2Q % growth | -0.10 | -0.11 | 0.01 | 12.62% |
| Q1 2023 Q2Q % growth | -0.10 9.09% | -0.14 | 0.04 | 27.91% |
| Q4 2022 Q2Q % growth | -0.14 6.03% | -0.14 | 0.00 | -3.12% |
| Q3 2022 Q2Q % growth | -0.12 50.00% | -0.13 | 0.01 | 8.09% |
| Q2 2022 Q2Q % growth | -0.10 56.52% | -0.13 | 0.03 | 22.19% |
| Q1 2022 Q2Q % growth | -0.11 47.62% | -0.16 | 0.05 | 32.60% |
| Q4 2021 Q2Q % growth | -0.15 34.78% | -0.19 | 0.04 | 22.60% |
| Q3 2021 Q2Q % growth | -0.24 11.11% | -0.24 | 0.00 | 1.14% |
| Q2 2021 Q2Q % growth | -0.23 8.00% | -0.23 | 0.00 | -0.97% |
| Q1 2021 Q2Q % growth | -0.21 16.00% | -0.24 | 0.03 | 11.04% |
| Q4 2020 Q2Q % growth | -0.23 50.00% | -0.23 | 0.00 | -1.83% |
| Q3 2020 Q2Q % growth | -0.27 75.45% | -0.22 | -0.05 | -22.55% |
| Q2 2020 Q2Q % growth | -0.25 45.65% | -0.24 | -0.01 | -2.12% |
| Q1 2020 Q2Q % growth | -0.25 34.21% | -0.32 | 0.07 | 21.94% |
| Q4 2019 Q2Q % growth | -0.46 | -0.37 | -0.09 | -24.58% |
| Q3 2019 Q2Q % growth | -1.10 | -0.27 | -0.83 | -306.96% |
| Q2 2019 Q2Q % growth | -0.46 | -0.38 | -0.08 | -21.07% |
| Q1 2019 Q2Q % growth | -0.38 | -0.33 | -0.05 | -15.52% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 10.739M 522.19% | 1.622M | 9.117M | 562.08% |
| Q1 2025 Q2Q % growth | 1.764M 15.14% | 1.815M | -51K | -2.81% |
| Q4 2024 Q2Q % growth | 1.574M -26.62% | 1.595M | -21K | -1.32% |
| Q3 2024 Q2Q % growth | 1.339M -71.25% | 1.898M | -559K | -29.45% |
| Q2 2024 Q2Q % growth | 1.726M -62.89% | 1.79M | -64K | -3.58% |
| Q1 2024 Q2Q % growth | 1.532M -77.09% | 2.769M | -1.237M | -44.67% |
| Q4 2023 Q2Q % growth | 2.145M -65.68% | 4.889M | -2.744M | -56.13% |
| Q3 2023 Q2Q % growth | 4.658M -21.71% | 4.847M | -189K | -3.90% |
| Q2 2023 Q2Q % growth | 4.651M -67.34% | 6.31M | -1.659M | -26.29% |
| Q1 2023 Q2Q % growth | 6.687M -46.84% | 6.149M | 538K | 8.75% |
| Q4 2022 Q2Q % growth | 6.25M 94.70% | 6.299M | -49K | -0.78% |
| Q3 2022 Q2Q % growth | 5.95M 78.14% | 9.561M | -3.611M | -37.77% |
| Q2 2022 Q2Q % growth | 14.24M 511.16% | 6.903M | 7.337M | 106.29% |
| Q1 2022 Q2Q % growth | 12.58M 496.21% | 4.455M | 8.125M | 182.38% |
| Q4 2021 Q2Q % growth | 3.21M 34.31% | 2.932M | 278K | 9.48% |
| Q3 2021 Q2Q % growth | 3.34M 119.74% | 2.432M | 908K | 37.34% |
| Q2 2021 Q2Q % growth | 2.33M 54.30% | 2.165M | 165K | 7.62% |
| Q1 2021 Q2Q % growth | 2.11M 41.61% | 3.372M | -1.262M | -37.43% |
| Q4 2020 Q2Q % growth | 2.39M 47.53% | 1.997M | 393K | 19.68% |
| Q3 2020 Q2Q % growth | 1.52M -50.33% | 1.696M | -176K | -10.38% |
| Q2 2020 Q2Q % growth | 1.51M 132.31% | 1.773M | -263K | -14.83% |
| Q1 2020 Q2Q % growth | 1.49M 119.12% | 1.326M | 164K | 12.37% |
| Q4 2019 Q2Q % growth | 1.62M | 1.931M | -311K | -16.11% |
| Q3 2019 Q2Q % growth | 3.06M | 5.381M | -2.321M | -43.13% |
| Q2 2019 Q2Q % growth | 650K | 802.485K | -152.485K | -19.00% |
| Q1 2019 Q2Q % growth | 680K | 1.261M | -581K | -46.07% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 31.11% | 63.53% | 34.02% | 26.46% |
| Revenue | -19.05% | -6.85% | 130.29% | 107.75% |